FDAFDA · Food and drugs·Recall number D-1057-2020
Tacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2047-01
Published April 1, 2020 · Recall initiated: March 23, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- TACROLIMUS
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- U.S.A. Nationwide
- UPC
- 0303782046014
- Lot
- Lot # 3105410, 3106268, Exp 9/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.